期刊文献+

降钙素原、C-反应蛋白在革兰阴性菌致病的老年下呼吸道感染疾病中的诊断价值研究 被引量:7

Diagnostic value of procalcitonin and C-reactive protein for gram-negative bacteria-caused lower respiratory tract infection in elderly patients
原文传递
导出
摘要 目的评价降钙素原(PCT)、C-反应蛋白(CRP)联合检测在革兰阴性菌致病的老年下呼吸道感染疾病中的诊断价值。方法回顾分析87例经确诊的下呼吸道感染的老年患者,依据感染类型分成3组,并与健康志愿者对照,比较不同感染类型的患者PCT、CRP水平差异,并利用ROC曲线分析PCT、CRP的诊断价值。结果细菌感染组、非细菌感染组的PCT、CRP水平与对照组比较差异具有统计学意义(P<0.05),其中革兰阴性细菌感染组的PCT水平明显高于革兰阳性细菌感染组,差异具有统计学意义(P<0.01)。绘制革兰阴性组和对照组的ROC曲线,计算出PCT和CRP的曲线下面积分别为0.966、0.928。结论 PCT、CRP检测应用于革兰阴性菌致病的老年下呼吸道感染疾病有明确的诊断价值,且PCT的诊断价值优于CRP。 Objective To evaluate the diagnostic value of procalcitonin( PCT) and C-reactive protein( CRP) for lower respiratory tract infections caused by Gram-negative pathogenic bacteria in elderly patients. Methods Retrospective analysis was performed. 87 elderly patients with diagnosed lower respiratory tract infections were divided into three groups according to the type of infection,and compared with healthy volunteers. The PCT and CRP levels in different type of infections were compared; the diagnostic values of PCT and CRP were analyzed by using ROC curves. Results The PCT and CRP levels in both Bacterial infection and non-bacterial infection groups were statistically different from those in control group( P 〈 0. 05). The PCT levels in Gram-negative bacterial infection was significantly higher than that in Gram-positive bacterial infection( P 〈 0. 01). Areas under the curve of PCT and CRP were 0. 966 and 0. 928 respectively according to the ROC curves of gram-negative group and the control group.Conclusion The PCT and CRP have a definite significance for differential diagnosis of elderly lower respiratory tract infection caused by Gram-negative bacteria,and the diagnostic value of PCT is higher than that of CRP.
出处 《中国微生态学杂志》 CAS CSCD 2014年第10期1188-1190,共3页 Chinese Journal of Microecology
关键词 降钙素原 C-反应蛋白 ROC曲线 革兰阴性菌 下呼吸道感染 Procalcitonin C-reactive protein ROC curves Gram-negative bacteria Lower respiratory tract infections
  • 相关文献

参考文献10

二级参考文献51

  • 1郭建秀,李鹏,伍艳芳,易维京,刘进军,郭鹰,唐捷,胡川闽.抗人MIF单克隆抗体的制备及其活性的初步鉴定[J].第三军医大学学报,2006,28(6):546-549. 被引量:4
  • 2郭杰标,郭锐,刘艳华.以抗体竞争结合抗原测定单抗亲和力常数的研究[J].南方医科大学学报,2006,26(7):1057-1059. 被引量:9
  • 3黄丽君,陈正跃,冯国富.降钙素原与可溶性细胞间黏附分子-1检测在新生儿败血症中的应用[J].实用儿科临床杂志,2006,21(15):1009-1009. 被引量:8
  • 4Dubos F, Korczowski B, Aygun D A, etal. Serum procalcito- nin level and other biological markers to distinguish between bacterial and aseptic meningitis in children., a European multi- center case cohort study[J]. Arch Pediatr Adolesc Med, 2008, 162 (12): 1157- 1163.
  • 5Kang Y A, Kwon S Y, Yoon H I, et al. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia [J].Korean J Intern Med, 2009,24(4) :337 - 342.
  • 6Oberhoffer M, Stonauns I, Russwurm S, etal. Proealcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related eytokines in vitro[J].J Lab Clin Med, 1999, 134(1) : 49 - 55.
  • 7Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in criti- cally ill patients admitted with suspected sepsis[J]. Am J Re- spit Crit Care Med, 2001, 164(3) :396 - 402.
  • 8Clec'h C, Ferriere F, Karoubi P, et al. Diagnostic and prog nostic value of procalcitonin in patients with septic shock[J]. Crit Care Med, 2004, 32(5) : 1166- 1169.
  • 9Ghorbani G. Procalcitonin role in differential diagnosis of in- fection stages and non infection inflammation[J]. Pak J Biol Sei, 2009, 12(4) :393-396.
  • 10Charles P E, Ladoire S, Aho S,et al. Serum procalcitonin ele- vation in critically ill patients at the onset of bacteremia caused by either gram-negative or gram-positive bacteria[J]. BMC In- feet Dis, 2008, 8: 38.

共引文献108

同被引文献77

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3052
  • 2陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:605
  • 3王质刚.血液净化学[M].3版.北京:北京科学技术出版社,2010:357-360.
  • 4Remington LT, Sligl WI. Community-acquired pneumonia[ J]. Curr Opin Pulm Med, 2014, 20(3) : 215-224.
  • 5Moulin F, Raymond J, Lorrot M, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia [ J ]. Arch Dis Child, 2001, 84(4): 332-336.
  • 6Bafadhel M, Clark TW, Reid C, et al. Procalcitonin and C-reac- tive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD [ J ]. Chest, 2011, 139(6): 1410-1418.
  • 7Simon L, Ganvin F, Amre DK, et al. Serum procalcitonin and C-reac- tive protein levels as nmrkers of bacterial infection : a systematic review and meta-analysis[J]. Clin Infect Dis, 2004, 39(2) : 206-217.
  • 8Horie M, Ugajin M, Suzuki M, et al. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia [ J ]. Am J Med Sci, 2012, 343(1): 30-35.
  • 9Masia M, Gutierrez F, Shum C, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index [ J ]. Chest, 2005, 128(4): 2223-2229.
  • 10Misra A, Singh M, Agarwal S. Proealcitonin As A Prognostic Bio- marker In Community Acquired Pneumonia [ J]. Am J Resp Crit Care, 2014, 189(1) : A4648.

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部